TransMedics (NSDQ:TMDX) shares took a massive hit today on first-quarter results that missed the consensus earnings forecast. TMDX shares were down -12.4% at $24.58 per share in midday trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down -1.2%. The Andover, Mass.-based organ transplant technology […]
Featured
Silk Road Medical sinks despite Street-beating Q1, raised guidance
Silk Road Medical (NSDQ:SILK) shares took a big hit today despite first-quarter results that beat the consensus forecast. SILK shares were down -10% at $55.30 per share in early-morning trading today. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — was down -0.9%. The Sunnyvale, Calif.-based company posted […]
Alcon dips despite Q1 earnings beat
Alcon (NYSE:ALC) stock is down today, even after the company reported first-quarter results that beat the consensus forecast. The Geneva, Switzerland-based company posted earnings per share of 17¢ on sales of $1.9 billion for the three months ended March 31, 2021, registering revenue growth of 4.8% year-over-year. Adjusted to exclude one-time items, earnings per share […]
Bruker reports nearly 31% sales growth in Q1, increases full-year guidance
Bruker Corp. (NSDQ:BRKR) posted first-quarter results today that beat the overall consensus on Wall Street and raised its full-year guidance as a result. The Billerica, Mass.-based company reported profits of $56.7 million, or 37¢ per share, on sales of $554.7 million for the three months ended March 31, for a bottom-line gain of 440% sales growth […]
Owens & Minor ticks up in pre-market trading on mixed Q1 results
Owens & Minor (NYSE:OMI) posted first-quarter results today that missed the consensus on Wall Street but raised its full-year guidance range for adjusted net income. The Richmond, Va.-based company reported profits of $69.589 million, or 98¢ per share, on sales of $2.327 billion for the three months ended March 31, for a sales growth of 9.61% […]
FDA could soon authorize Pfizer COVID-19 vaccine for younger adolescents
The COVID-19 vaccine from Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX) appears to be on the cusp of winning regulatory authorization for use in adolescents between the ages of 12 and 15, according to several media reports. FDA has authorized the vaccine for people aged 16 and up. In March, Pfizer submitted clinical trial results to FDA, suggesting the efficacy of the […]
FDA clears Life Spine’s ProLift lateral HELO fixation system
Life Spine announced today that it received FDA marketing clearance for its ProLift lateral HELO fixation system. Huntley, Ill.-based Life Spine touts the ProLift lateral HELO fixation system, an expendable lateral spacer with an integrated plating system designed for the restoration of disc height while providing additional lateral stabilization, as capable of saving time and […]
Smiths Medical partners with Ivenix on infusion management suite
Smiths Medical announced today that it partnered with Ivenix to offer a comprehensive suite of infusion management solutions. Minneapolis-based Smiths Medical will provide a strategic investment for the long-term partnership that intends to “revolutionize” infusion management and improve patient safety while meeting the needs of healthcare providers, according to a news release. Get the full story at our […]
Zimmer Biomet dips despite Street-beating Q1
Zimmer Biomet (NYSE:ZBH) shares took a hit today despite first-quarter results that topped the consensus forecast. The Warsaw, Ind.-based company posted profits of $198.1 million, or 94¢ per share, on sales of more than $1.8 billion for the three months ended March 31, 2021 — a massive bottom-line gain compared with losses of more than […]
Henry Schein beats The Street in Q1, raises guidance
Henry Schein (NSDQ:HSIC) raised its 2021 guidance after reporting first-quarter financial results that topped the consensus forecast. The Melville, N.Y.-based company posted profits of $166 million, or $1.16 per share, on sales of $2.9 billion for the three months ended March 27, 2021, for a 27.4% bottom-line gain on sales growth of 20.4% year-over-year. Adjusted to […]
Neuroelectrics raises $17.5M Series A
Brain stimulation technology developer Neuroelectrics announced today that it raised $17.5 million in a Series A financing. Morningside Ventures led the funding round, the proceeds for which are earmarked for the development of Neuroelectrics’ non-invasive transcranial electrical stimulation (tES) platform. Cambridge, Mass./Barcelona, Spain-based Neuroelectrics plans to use funds to advance clinical trials for the platform […]